Most practices do not choose between the PHQ-2 and the PHQ-9. They use both, in sequence: a two-item screen for everyone, and the full nine items only for those who screen positive. This page covers running that workflow, scoring it, and billing for it. For a head-to-head look at the two instruments, see PHQ-2 vs PHQ-9.
The answer depends on your clinical context. These aren't competing tools. They're complementary instruments designed for different purposes.
The instruments
The PHQ-2 consists of two questions, the first two items from the PHQ-9: loss of interest or pleasure in doing things, and feeling down, depressed, or hopeless. Each rated 0-3, total score 0-6. Its purpose is quick identification of patients who may have depression and warrant further assessment.
The PHQ-9 covers all nine DSM-5 criteria for major depressive disorder: anhedonia, depressed mood, sleep disturbance, fatigue, appetite changes, worthlessness/guilt, concentration difficulties, psychomotor changes, and suicidal ideation. Its total score is 0-27. After any scored symptom is endorsed, Survey Doctor offers an optional functional question and stores the answer separately from the total. It works as a screening tool, severity measure, and repeatable symptom measure.
Psychometric comparison
A 2020 JAMA meta-analysis of 100 studies (44,318 participants) established the definitive numbers:
| Measure | Threshold | Sensitivity | Specificity |
|---|---|---|---|
| PHQ-2 | ≥3 | 76% | 87% |
| PHQ-9 | ≥10 | 88% | 85% |
| PHQ-2 (≥2) → PHQ-9 (≥10) | Tiered | 85% | 89% |
PHQ-2 is designed for high specificity at the ≥3 threshold, but using a ≥2 cutoff followed by PHQ-9 captures more cases. The tiered approach reduced the number of patients needing the full PHQ-9 by 57% while maintaining sensitivity comparable to PHQ-9 alone (Levis et al., 2020).
What this means clinically: the PHQ-2 reduces screening burden but still misses some depression cases. The PHQ-9 refines a positive screen; it does not confirm a diagnosis. Clinical context remains necessary at both stages.
When to use PHQ-2
Universal screening where efficiency matters: primary care wellness visits, ED triage, annual health assessments, large population screening. PHQ-2's 30-second administration makes universal screening practical.
High-volume settings where throughput matters: busy primary care clinics, community health centers, intake processes with many components. Two questions fit where nine might not.
Non-mental health specialty settings where depression screening isn't the primary focus: cardiology (depression is common in heart disease), oncology, chronic disease management, obstetric care. Brief screening fits more easily into specialty workflows.
Resource-limited contexts with limited behavioral health access, constrained follow-up capacity, or staff not trained in mental health assessment. Better to screen briefly than not screen at all.
When to use PHQ-9
Confirming positive PHQ-2 screens, the classic tiered approach. This uses PHQ-9's better specificity to filter PHQ-2's false positives while maintaining high sensitivity overall.
Describing depression symptom severity. PHQ-9 provides five descriptive bands. No band selects treatment or care intensity:
- 0-4: Minimal
- 5-9: Mild
- 10-14: Moderate
- 15-19: Moderately severe
- 20-27: Severe
PHQ-2 doesn't differentiate severity.
Repeated symptom review. PHQ-9 covers nine symptom areas and can support comparisons between complete results. A score change describes reported symptoms; it does not prove treatment response or choose care. PHQ-2 is too brief for the same item-level review.
Mental health specialty settings where depression is the focus: psychiatry practices, psychotherapy practices, depression treatment programs. You want the full picture, not just a quick screen.
Suicide risk identification. PHQ-9 item 9 specifically asks about suicidal ideation. PHQ-2 doesn't include this. For populations at elevated suicide risk, PHQ-9 provides safety screening that PHQ-2 cannot. (Note: item 9 has limited sensitivity for acute suicide risk and any positive response should trigger clinical evaluation, not substitute for a full safety assessment.)
If you need help now. In the US, Call 988 or text 988. Call 911 if you are in immediate danger. Outside the US, contact your local emergency number or find support in your country.
Quality measurement requirements. Many metrics specify PHQ-9: HEDIS depression measures, MIPS quality measures, value-based care contracts.
The tiered screening approach
The tiered approach works like this: administer PHQ-2 to all patients, score immediately, administer PHQ-9 if score ≥3 (or ≥2 for higher sensitivity), then use PHQ-9 results to guide clinical response.
This saves time because roughly 75-80% of patients screen negative on the PHQ-2. Some cases are still missed, so symptoms, history, and clinical judgment can justify a PHQ-9 after a negative screen.
Example implementation: In a primary care practice screening 100 patients, about 75 may screen PHQ-2 negative and leave the routine stepped workflow. A negative result does not override symptoms, history, or safety concerns. Of the 25 who screen positive, roughly half may have a PHQ-9 score of 10 or higher that warrants clinical evaluation.
When to skip PHQ-2 and go straight to PHQ-9
Mental health settings where depression is expected to be common. The efficiency of PHQ-2 offers little advantage here.
Treatment monitoring where you need PHQ-9 anyway.
High-risk populations with expected high positivity rates, since many patients need PHQ-9 regardless.
Suicide screening needed since item 9 provides safety information.
Quality measure requirements that specify PHQ-9.
PHQ-9 takes 2-3 minutes vs. 30 seconds for PHQ-2. In some contexts the extra time is acceptable: patients completing electronically before appointments, mental health intake processes, or already-identified depression patients. Time matters more in high-volume brief encounters than in scheduled mental health appointments.
Combining with other measures
PHQ-2 + GAD-2 (or the integrated PHQ-4) screens for both depression and anxiety in under a minute. Useful for general mental health screening, primary care triage, and population health programs. Followed by full PHQ-9 and/or GAD-7 for positives.
PHQ-9 + GAD-7 gives a thorough assessment of depression and anxiety in 4-5 minutes. Standard in many mental health settings.
For perinatal populations, consider the EPDS, which is specifically validated for that context, though PHQ-2/PHQ-9 tiered approach also works.
Scoring quick reference
PHQ-2: Score 0-2 is a negative screen, but it does not rule out depression. Use symptoms and clinical context to decide whether to administer the PHQ-9. Score 3-6 is positive and should prompt the PHQ-9 or clinical assessment.
PHQ-9: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, and 20-27 severe. These bands describe reported symptom frequency. They do not diagnose depression or prescribe an intervention, treatment, or referral.
The published PHQ-9 form also includes an unscored functional question about work, home responsibilities, and relationships. Survey Doctor shows it after any scored symptom is endorsed, then stores an optional answer separately from the total. Historical, manual, and imported rows without companion data mean it was not collected. Ask about functioning directly because a high symptom score with minimal impairment differs clinically from a high score with severe impairment.
Billing considerations
Both PHQ-2 and PHQ-9 qualify for 96127 billing when administered, scored, and documented with clinical interpretation. With the tiered approach, you can bill for the PHQ-2, and if positive, bill for the PHQ-9 as well (typically up to 2 units total per visit).
---
Survey Doctor offers both the PHQ-2 and PHQ-9 with automatic scoring and clinical interpretation. Choose a plan to start screening patients with progress tracking over time.